Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
22.23B
Market cap22.23B
Price-Earnings ratio
22.94
Price-Earnings ratio22.94
Dividend yield
1.60%
Dividend yield1.60%
Average volume
785.50K
Average volume785.50K
High today
$203.00
High today$203.00
Low today
$199.97
Low today$199.97
Open price
$200.34
Open price$200.34
Volume
217.04K
Volume217.04K
52 Week high
$213.50
52 Week high$213.50
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

The current Quest Diagnostics(DGX) stock price is $202.34, with a market capitalization of 22.23B. The stock trades at a price-to-earnings (P/E) ratio of 22.94 and offers a dividend yield of 1.6%.

As of 2026-03-12, Quest Diagnostics(DGX) stock has fluctuated between $199.97 and $203.00. The current price stands at $202.34, placing the stock +1.2% above today's low and -0.3% off the high.

Quest Diagnostics(DGX) shares are trading with a volume of 217.04K, against a daily average of 785.5K.

During the past year, Quest Diagnostics(DGX) stock moved between $157.20 at its lowest and $213.50 at its peak.

During the past year, Quest Diagnostics(DGX) stock moved between $157.20 at its lowest and $213.50 at its peak.

DGX News

Simply Wall St 1d
Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test

Quest Diagnostics (NYSE:DGX) has partnered with Guardant Health to offer the FDA approved Shield blood test for colorectal cancer screening. The agreement will...

Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test
Nasdaq 2d
Should You Continue to Hold DGX Stock in Your Portfolio?

Quest Diagnostics DGX is well-poised to grow in the coming quarters owing to its investments in advanced diagnostics to deliver and scale innovative services. T...

Should You Continue to Hold DGX Stock in Your Portfolio?
Simply Wall St 4d
A Look At Quest Diagnostics Valuation After Recent Share Price Momentum

Advertisement Why Quest Diagnostics Stock Is on Investors’ Radar Quest Diagnostics (DGX) is back in focus after recent trading, with the share price last clos...

A Look At Quest Diagnostics Valuation After Recent Share Price Momentum

Analyst ratings

50%

of 22 ratings
Buy
45.5%
Hold
50%
Sell
4.5%

More DGX News

Nasdaq 7d
Implied Volatility Surging for Quest Diagnostics Stock Options

Investors in Quest Diagnostics Incorporated DGX need to pay close attention to the stock based on moves in the options market lately. That is because the March...

Implied Volatility Surging for Quest Diagnostics Stock Options

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.